Difference between revisions of "Template:Current week ecosystem agenda"

Revision as of 08:46, 19 September 2022

Oroboros declares solidarity against the Russian aggression-war in Ukraine and against all aggression-wars worldwide. - »More details

-» A future for Ukraine is the future of its science

2022 Week 38

Sep-19 Mo

World Mitochondrial Disease Week – Sep 18-24

World Mitochondrial Disease Week raises awareness of mitochondrial disease through educational, fundraising and advocacy activities.
See what is happening near you - »https://mitochondrialdiseaseweek.org/events/

Sep-20 Tu

Bioenerg Commun 2022.4: A review on the current landscape of mitochondrial disease drug development

Åsander Frostner E, Simón Serrano S, Chamkha I, Donnelly E, Elmér E, Hansson MJ (2022) Towards a treatment for mitochondrial disease: current compounds in clinical development. https://doi.org/10.26124/bec:2022-0004

from the O2k-Network »SE Lund Elmer E«

Sep-21 We

»The 77th Japanese Society of Physical Fitness and Sports Medicine 2022 Tochigi JP« Sep 21-23

"By tracing the carbon flow of the nutrients glucose and glutamine in cells derived from patients with different genetically defined causes of primary mitochondrial diseases (PMD), we identified several key metabolic changes supporting the major importance of an NAD⁺/NADH imbalance in PMD."

Adant I, Bird M, Decru B, Windmolders P, Wallays M, de Witte P, Rymen D, Witters P, Vermeersch P, Cassiman D, Ghesquière B (2022) Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction. »Bioblast link«

from the O2k-Network »BE Leuven Vermeersch P«

Sep-22 Th

»BEC tutorial-Living_Communications pmF« Prague, Sep 22

»EMC2022 Prague CZ« Sep 22-26

Sep-23 Fr

Investigating the cause of late-onset SLC25A26-related mitochondrial disease

Schober FA, Tang JX, Sergeant K, Moedas MF, Zierz CM, Moore D, Smith C, Lewis D, Guha N, Hopton S, Falkous G, Lam A, Pyle A, Poulton J, Gorman GS, Taylor RW, Freyer C, Wredenberg A (2022) Pathogenic SLC25A26 variants impair SAH transport activity causing mitochondrial disease. »Bioblast link«

from the O2k-Network »BE Leuven Vermeersch P«

Sep-24 Sa

Sep-25 Su

-» 12:10 (GMT+2): Erich Gnaiger presenting at EMC2022 Prague CZ - Body mass excess, muscle mass, obesity and mitochondrial fitness

@@ Line 1: / Line 1: @@
 {{Template:Science for Ukraine}}
-Week 37
+Week 38
-*'''Sep-12 Mo'''
+*'''Sep-19 Mo'''
 :{|
-| width="100" align="center" |[[File:MitoFit Preprints.png|100px|link=https://wiki.oroboros.at/index.php/Torres-Quesada_2022_MitoFit|MitoFit pdf]]
+| width="100" align="center" | [[Image:MitoGlobal.jpg|45px|link=https://www.mitoglobal.org/index.php/MitoGlobal_Events|MitoGlobal Events]]
-|'''From the [[MitoKIN]] project - preprint to publication:'''<br>
+| '''World Mitochondrial Disease Week''' – Sep 18-24<br>
-* Torres-Quesada O, Doerrier C, Strich S, Gnaiger E, Stefan E (2022) Physiological cell culture media tune mitochondrial bioenergetics and drug sensitivity in cancer cell models. [[Torres-Quesada 2022 Cancers (Basel)|https://doi.org/10.3390/cancers14163917]]
+World Mitochondrial Disease Week raises awareness of mitochondrial disease through educational, fundraising and advocacy activities.<br>
-:from the O2k-Network »[[AT Innsbruck Oroboros]]«
+See what is happening near you - »https://mitochondrialdiseaseweek.org/events/
 |}
 ----
-*'''Sep-13 Tu'''
+*'''Sep-20 Tu'''
+:{|
+| width="100" align="center" |[[File:2022.4.jpg|100px|link=https://doi.org/10.26124/bec:2022-0004 |Åsander Frostner 2022 BEC]]
+|'''Bioenerg Commun 2022.4: A review on the current landscape of mitochondrial disease drug development'''<br>
+*Åsander Frostner E, Simón Serrano S, Chamkha I, Donnelly E, Elmér E, Hansson MJ (2022) Towards a treatment for mitochondrial disease: current compounds in clinical development. https://doi.org/10.26124/bec:2022-0004
+:from the O2k-Network »[[SE Lund Elmer E]]«
+|}
 ----
-*'''Sep-14 We'''
+*'''Sep-21 We'''
+:::: '''»[[The 77th Japanese Society of Physical Fitness and Sports Medicine 2022 Tochigi JP]]«''' Sep 21-23
 :{|
-| width="100" align="center" |[[File:2022 9 GA.jpg|right|150px|link=https://doi.org/10.26124/bec:2022-0009 |Posch 2022 BEC]]
-|'''Bioenerg Commun 2022.9:'''A publication with video presentation from [[Bioblast 2022 |Bioblast 2022: BEC Inaugural Conference]] <br>
+| width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
-*Posch W, Dichtl S, Zaderer V, Lass-Flörl C, Wilflingseder D (2022) How to optimize respiratory models for SARS-CoV-2 research. https://doi.org/10.26124/bec:2022-0009
+|''' "By tracing the carbon flow of the nutrients glucose and glutamine in cells derived from patients with different genetically defined causes of primary mitochondrial diseases (PMD), we identified several key metabolic changes supporting the major importance of an NAD<sup>+</sup>/NADH imbalance in PMD." '''<br>
+*Adant I, Bird M, Decru B, Windmolders P, Wallays M, de Witte P, Rymen D, Witters P, Vermeersch P, Cassiman D, Ghesquière B (2022) Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction. [[Adant 2022 Mol Metab|»Bioblast link«]]
+:from the O2k-Network »[[BE Leuven Vermeersch P]]«
 |}
+----
+*'''Sep-22 Th'''
+:::: '''»[[MiPNet27.06 BEC tutorial-Living_Communications pmF |BEC tutorial-Living_Communications ''pmF'']]«''' Prague, Sep 22
+:::: '''»[[EMC2022 Prague CZ]]«''' Sep 22-26
 ----
-*'''Sep-15 Th''' - World Lymphoma Awareness Day
+*'''Sep-23 Fr'''
 :{|
 | width="100" align="center" |[[Image:O2k-Publications.jpg|70px|link=http://wiki.oroboros.at/index.php/O2k-Publications:_Topics |O2k-Publications in the MiPMap]]
-|'''OXPHOS as a potential therapeutic target in classical Hodgkin lymphoma'''<br>
+|'''Investigating the cause of late-onset ''SLC25A26''-related mitochondrial disease'''<br>
-*Birkenmeier K, Droese S, Wittig I, Winkelmann R, Käfer V, Doering C, Hartmann S, Wenz T, Reichert AS, Brandt U, Hansmann ML (2016) Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma are highly dependent on oxidative phosphorylation. Int J Cancer 138:2231-46. [[Birkenmeier 2016 Int J Cancer|»Bioblast link«]]
+*      Schober FA, Tang JX, Sergeant K, Moedas MF, Zierz CM, Moore D, Smith C, Lewis D, Guha N, Hopton S, Falkous G, Lam A, Pyle A, Poulton J, Gorman GS, Taylor RW, Freyer C, Wredenberg A (2022) Pathogenic SLC25A26 variants impair SAH transport activity causing mitochondrial disease.  [[Schober 2022 Hum Mol Genet|»Bioblast link«]]
+:from the O2k-Network »[[BE Leuven Vermeersch P]]«
-:from the O2k-Network »[[DE Frankfurt Droese S]]«, »[[DE Frankfurt Wittig I]]« and »[[NL Nijmegen Brandt U]]«
 |}
+----
+*'''Sep-24 Sa'''
 ----
+*'''Sep-25 Su'''
-*'''Sep-16 Fr'''
+::::-» '''12:10 (GMT+2): [[Gnaiger Erich|Erich Gnaiger]] presenting at [[EMC2022 Prague CZ]]''' - ''[[Gnaiger 2020 PaduaMuscleDays |Body mass excess, muscle mass, obesity and mitochondrial fitness]]''<br>
-:::: '''»[[Europhysiology 2022 Copenhagen DK]]«''' Sep 16-18
+----